about
A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestationsClose temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.Reference values of diffusing capacity of non-smoking Chinese in Hong Kong.Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis.The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in sclerodermaT cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.Change in pulmonary diffusion capacity in a general population sample over 9 years.Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients.Effect of a patent foramen ovale in humans on thermal responses to passive cooling and heating.Fibrosing myopathy in systemic sclerosis associates with higher mortality.Intrapulmonary arteriovenous anastomoses in humans with chronic obstructive pulmonary disease: implications for cryptogenic stroke?Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.Higher oesophageal temperature at rest and during exercise in humans with patent foramen ovale.AltitudeOmics: impaired pulmonary gas exchange efficiency and blunted ventilatory acclimatization in humans with patent foramen ovale after 16 days at 5,260 m.Determination of carboxyhaemoglobin in humans following low-level exposures to carbon monoxide.Effects of exhaustive endurance exercise on pulmonary gas exchange and airway function in women.Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor).Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect.Gas exchange during exercise in habitually active asthmatic subjects.AltitudeOmics: Effect of reduced barometric pressure on detection of intrapulmonary shunt, pulmonary gas exchange efficiency, and total pulmonary resistance.Reference values for pulmonary diffusing capacity for adult native Finns.Exercise-induced intrapulmonary arteriovenous shunting in healthy humans.Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning.Sildenafil, nifedipine and acetazolamide do not allow for blood flow through intrapulmonary arteriovenous anastomoses during exercise while breathing 100% oxygen.Increased cardiac output, not pulmonary artery systolic pressure, increases intrapulmonary shunt in healthy humans breathing room air and 40% O2.Normative reference values for lung transfer factor in Isfahan, Iran.
P2860
Q30993697-C5BF0CE2-75C0-4507-8932-3A0D98EC4A92Q34159164-C06A366E-A20C-42D2-BC19-EBC710D51D73Q34641004-3B057F2F-CB3C-4531-86C1-7D2E049437C5Q35454043-E1766B28-02AE-477E-91DD-B4A33FBBCBF4Q35923222-2B0EBE19-037B-49B3-96BD-A827A8EACD92Q36087017-42BC6C2C-E52B-4915-9BB4-E9EB22A0ABE4Q36403167-80627A7A-B825-4652-A1F5-BDDF26AB2E3DQ36645934-636F70E3-301F-4C93-A24F-12990A375374Q36871425-E8F62E97-97A2-47D7-A7F5-7E54D6DD788AQ37143961-7B3BE23B-1076-4A36-9063-DA4933582DE8Q37236188-B6A3BA8E-8110-4B0B-AB95-C79217BEC4F7Q37340271-27874C58-61B6-42CC-A19A-3AB52822E77DQ38619200-805A4605-23AA-40DA-84B4-B6B0FD6E63D4Q38763676-785BE432-0090-4DBD-ABC9-CCB398756203Q38849058-B419181C-E41B-4C2D-A015-F652050198EDQ39993595-A542FBD5-9779-4712-8EA7-011F6ED6C4ACQ40738918-59572883-3C56-41DC-A6F5-78D42DA7097CQ41440710-63D84127-1242-407E-90A3-EDCC0B9D2908Q43463273-13759675-0509-4348-A776-8F3EA25D0773Q43678649-165DAA31-2D24-4F1C-9FDE-9A1663F3F0D4Q43711060-3680A958-3139-47D9-B7F7-5253AB99F6ABQ43829862-2C6CCA70-3420-4BD2-8D6E-BC3586841D70Q46604577-76E6C13F-73C1-4D85-A723-1695BBD5C99AQ47557938-A8837135-FFA5-4E33-B002-755E546724B2Q47969667-571929D3-3B64-4D42-9B81-DF85B3738611Q47989813-85BD2623-8279-4835-91C8-4E93E630E1CDQ51427894-C1A1673E-E1A4-40C9-8EDA-5266F4C46AC5Q51694952-F86CC80C-A602-494A-A452-370E53580C42Q51706603-DDBD4253-C7FE-4C1F-BF8F-1185888CDC2BQ51939917-17CE7169-FFE5-4E8C-A32C-D40448739F6C
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 1987
@uk
name
The Single-Breath Carbon Monoxide Diffusing Capacity
@en
The Single-Breath Carbon Monoxide Diffusing Capacity
@nl
type
label
The Single-Breath Carbon Monoxide Diffusing Capacity
@en
The Single-Breath Carbon Monoxide Diffusing Capacity
@nl
prefLabel
The Single-Breath Carbon Monoxide Diffusing Capacity
@en
The Single-Breath Carbon Monoxide Diffusing Capacity
@nl
P2093
P1476
The Single-Breath Carbon Monoxide Diffusing Capacity
@en
P2093
Benjamin Burrows
Dwyn E. Knudson
Ronald J. Knudson
Walter T. Kaltenborn
P304
P356
10.1164/ARRD.1987.135.4.805
P577
1987-04-01T00:00:00Z